Argos Therapeutics Inc (ARGS:NAS): Analytics, Extensive Financial Metrics, and
Benchmarks Against Averages and Top Companies Within its Industry
Key Findings: - Unique new report provides deep financial benchmarks for (Argos Therapeutics Inc (ARGS:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. - Benchmarking study for (Argos Therapeutics Inc ) includes growth forecast for its primary industry to the year 2024. The purpose of this report is to provide vital corporate-specific benchmarks, comparing the Subject Company to its top competitors (on a company-by-company basis) and to the averages within its primary industry for all key metrics. This is a unique report containing high-value data. The report begins with a superb overview of the primary industry of the Subject Company, including historical industry revenues, revenue forecasts and CAGR. Then the report moves into industry averages and metrics, then into data specific to the Subject Company, with comparative data for the Subject Company’s top competitors. This report will save countless hours of research and analytical work for the end user.
Core Benefits to Customer: 1) Comprehensive benchmarks for the Subject Company: a. Benchmarked against the leading firms in its primary industry b. Benchmarked against the average for publicly-held companies (U.S.) in its industry. c. This includes financial results, ratios, vital statistics and metrics in one package, including historical and current metrics and averages for 6 years within its primary industry. 2) A snapshot overview of the company’s primary industry, including current and historic revenues and employment, along with a long term forecast for industry growth, with CAGR (compound annual growth rate), employee population and much more. 3) Detailed rankings of the Subject Company against top companies within the industry (U.S.-based firms) for key items including: a. Approximate market capitalization b. Employees c. Revenues d. Net income e. 3-Year revenue growth (%) f. 3-Year income growth (%) g. Return on assets (%) h. Return on equity (%) i. Return on invested capital (%) 4) Leading companies-profiles of the Subject Company as well as profiles of top competitors within the industry Pages: 84 Statistical Tables Provided: 28 Charts Provided: 14 Geographic: US This report is part of the Plunkett’s Corporate
Benchmarks series, published by the Plunkett Analytics unit of Plunkett Research, Ltd.
Designed to benefit: - Analysis and Financial Modeling -Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants
Companies Profiled: - Johnson & Johnson - Procter & Gamble Co - Pfizer Inc - Dow Chemical Company (The) - Merck & Co Inc - Gilead Sciences Inc - AbbVie Inc - DuPont (E I du Pont de Nemours & Co) - ExxonMobil Chemical - Amgen Inc
Our reports have been used by over 10K customers, including:
The Global Data Historian Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2028. Some of the prominent trends that the market is witnessing include increasing demand for consolidated data for process and performance improvement, growing need for industrial 360...
The global level transmitter market size is expected to grow from USD 3.1 billion in 2020 to USD 3.5 billion by 2025, at a CAGR of 2.6%. The growth of the market is attributed to high focus on industrial automation and optimum utilization of resources, increased regulatory emphasis on industrial safety, growing demand for level transmitters...
The Asia Pacific medical writing market is expected to reach US$ 983.51 million by 2027 from US$ 560.59 million in 2019; it is anticipated to grow at a CAGR of 7.3% during 2020–2027. The growth of Asia Pacific medical writing market is driven by increasing number of market players and growing government support in the healthcare sector....
184 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Acetic Anhydride has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
169 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Dimethylformamide has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The global analytical standards market size is projected to reach USD 1.7 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 6.3%. Factors such as the increasing adoption of analytical techniques in pesticide monitoring are propelling the growth of the analytical standards market. Additionally, expected patent expiry of major drugs...
275 pages •
By Asia Market Information & Development Company
• Jan 2021
China’s demand for Pharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption...
The cooler box market is estimated to be valued at USD 4.6 billion in 2020 and is projected to reach USD 8.1 billion by 2025, at a CAGR of 12.1% from 2020 to 2025 Growth in the pharmaceutical industry, ongoing COVID-19 vaccination drives, transportation of processed and fresh fruits, vegetables, dairy products, and other perishable food products...
The Global Pharmaceutical CDMO Market was valued USD 160.12 billion in 2020, and it is expected to reach USD 236.61 billion by 2026, registering a CAGR of 6.5%, during the period of forecast period (2021-2026). The CMO/CDMO service sector is uniquely positioned to address some of the challenges that drug developers are facing amid the COVID-19...
Pharmaceutical
World
Europe
North America
APAC
South Africa
Pharmaceutical Production
Health Expenditure
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.